(Total Views: 92)
Posted On: 10/09/2023 8:33:30 AM
Post# of 108957
$RGBP News!! Goldman Small Cap Research Publishes New Research Report on Regen BioPharma, Inc.
BALTIMORE, MD / ACCESSWIRE / October 4, 2023 / Goldman Small Cap Research, a stock market research firm specializing in the small cap and microcap sectors, announced today that it has published a new research report on Regen BioPharma, Inc. (OTCPK:RGBP). Leveraging its deep IP and surprising results from Phase I of in vitro experiments, Regen may be poised to initiate a Phase I clinical trial in the large autoimmune therapeutic category. The Goldman report carries a price target. To view the new research report, along with disclosures and disclaimers, or to download the report in its entirety, please visit: https://bit.ly/48BJkGG.
https://www.marketwatch.com/press-release/gol...ws_seemore
BALTIMORE, MD / ACCESSWIRE / October 4, 2023 / Goldman Small Cap Research, a stock market research firm specializing in the small cap and microcap sectors, announced today that it has published a new research report on Regen BioPharma, Inc. (OTCPK:RGBP). Leveraging its deep IP and surprising results from Phase I of in vitro experiments, Regen may be poised to initiate a Phase I clinical trial in the large autoimmune therapeutic category. The Goldman report carries a price target. To view the new research report, along with disclosures and disclaimers, or to download the report in its entirety, please visit: https://bit.ly/48BJkGG.
https://www.marketwatch.com/press-release/gol...ws_seemore
(0)
(0)
